Benjamin Halladay - Net Worth and Insider Trading
Benjamin Halladay Net Worth
The estimated net worth of Benjamin Halladay is at least $2 Million dollars as of 2026-08-04. Benjamin Halladay is the CFO of Esperion Therapeutics Inc and owns about 702,829 shares of Esperion Therapeutics Inc (ESPR) stock worth over $2 Million. Details can be seen in Benjamin Halladay's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Benjamin Halladay has not made any transactions after 2026-06-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Benjamin Halladay
Benjamin Halladay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Benjamin Halladay owns 1 companies in total, including Esperion Therapeutics Inc (ESPR) .
Click here to see the complete history of Benjamin Halladay’s form 4 insider trades.
Insider Ownership Summary of Benjamin Halladay
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2026-06-17 | Chief Financial Officer |
Benjamin Halladay Latest Holdings Summary
Benjamin Halladay currently owns a total of 1 stock. Benjamin Halladay owns 702,829 shares of Esperion Therapeutics Inc (ESPR) as of June 17, 2026, with a value of $2 Million.
Latest Holdings of Benjamin Halladay
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2026-06-17 | 702,829 | 3.18 | 2,234,996 |
Holding Weightings of Benjamin Halladay
Benjamin Halladay Form 4 Trading Tracker
According to the SEC Form 4 filings, Benjamin Halladay has made a total of 11 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Esperion Therapeutics Inc is the sale of 10,773 shares on June 17, 2026, which brought Benjamin Halladay around $34,043.
Insider Trading History of Benjamin Halladay
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Benjamin Halladay Trading Performance
Benjamin Halladay Ownership Network
Ownership Network List of Benjamin Halladay
Ownership Network Relation of Benjamin Halladay

Benjamin Halladay Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Benjamin Halladay is the Chief Financial Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Operating Officer Sheldon L. Koenig , General Counsel Benjamin Looker , and Chief Commercial Officer Harlow John B. Jr. .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Benjamin Halladay made 9 insider transaction in Esperion Therapeutics Inc (ESPR) with a net sale of 42,374. Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 40,979 shares made by Benjamin Looker , a net sale of 199,358 shares made by Sheldon L. Koenig , and a net sale of 2,780 shares made by Eric Warren .
In summary, during the past 3 months, insiders sold 76,185 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 76,185 shares. During the past 18 months, 285,491 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 285,491 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Benjamin Halladay Mailing Address
Above is the net worth, insider trading, and ownership report for Benjamin Halladay. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Benjamin Halladay's mailing address is: Ann Arbor Mi 48108.